Chemotherapy doses were specifically adjusted for neutropenia, thrombocytopenia, nausea, vomiting, diarrhoea, and peripheral sensory neuropathy and for grade ⩾3 toxicities possibly related to chemotherapy.
Several cohorts specifically adjusted for smoking (estimates 11, 25, 29, 30, 68) and in some others estimates of smoking prevalence in subsets suggest that they were similar to that of the general population (estimates 43, 50, 51).
GOseq specifically adjusts for the higher abundance of reads from long or highly expressed genes in RNA-seq experiments when assessing a gene list for over-representation of biological functions [ 22].
In this prospective study, we adjusted for plausible patient and treatment-related risk factors for mortality, specifically adjusting for differences in severity of illness using three different ICU measures which were not colinear, and all remained statistically associated with mortality in our final multivariable model.
More specifically, adjusting for demographic, home and area characteristics, the present analysis was performed to subsequently test: Whether actual (objectively measured) distance and perceived (self-reported) proximity to BS are associated with report of NSPS, controlling for actual and perceived proximity to powerlines.
Specifically, adjusted OGIS was 82 104 mL/min/m higher for transplant versus nontransplant subjects.
Specifically, we adjusted for age, diabetes, liver disease, malignancy and chronic renal failure.
More specifically, we adjusted for seasonality and fit several PAR(p) models varying the order (p) and selected the model that resulted in the lowest BIC.
Specifically, we adjusted for patients' baseline severity reflected by the SAPS II score and for organ dysfunctions before administration of ICM reflected by the non-renal SOFA score (SOFA - renal component).
Specifically, we adjusted for sex, age (continuous), ever-smoking status, season of infection [winter (December February) vs. all other seasons combined], physician order for an antibiotic in the 365 to 14 days preceding diagnosis, and ever-receiving Medical Assistance as health insurance [as a surrogate for low individual socioeconomic status (Bratu et al. 2006; Casey et al. 2013b)].
6 In our series, we developed a computerised algorithm which specifically adjusts parameters for individual patients and has enabled clinicians to achieve a high level of control with a TTR of over 75%.
